0001415889-24-005668.txt : 20240228 0001415889-24-005668.hdr.sgml : 20240228 20240228124315 ACCESSION NUMBER: 0001415889-24-005668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gendreau Roger Michael CENTRAL INDEX KEY: 0001826131 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39811 FILM NUMBER: 24692624 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Virios Therapeutics, Inc. CENTRAL INDEX KEY: 0001818844 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 854314201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 8666208655 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Virios Therapeutics, LLC DATE OF NAME CHANGE: 20200721 4 1 form4-02282024_050208.xml X0508 4 2024-02-26 0001818844 Virios Therapeutics, Inc. VIRI 0001826131 Gendreau Roger Michael C/O VIRIOS THERAPEUTICS, INC. 44 MILTON AVENUE ALPHARETTA GA 30009 false true false false CHIEF MEDICAL OFFICER 0 Stock Option (right to buy) 0.357 2024-02-26 4 A 0 88085 0 A 2034-02-26 Common Stock 88085 88085 D The stock option will vest 100% on February 26, 2025, one year following the grant date. /s/ Greg Duncan, Attorney-in-Fact 2024-02-28